NCT05448079

Brief Summary

This study was conducted as a randomized pretest-posttest study to examine the effect of sexual counseling based on the PLISSIT model on post-menopausal women's sexual functions, marital adjustment and quality of sexual life. Sixty women (Experimental=30, Control=30) that applied to the menopause policlinic of a Women Diseases Training and Research Hospital were included in the study. Two women dropped out later, so the study was completed with 58 (Experimental=29, Control=29) women. Firstly, women were separated into two groups according to the cut-point of (26,55) in The Female Sexual Function Index (FSFI) (those who score 26,6 and above or 26,5 and below) and then these two groups were divided into intervention and control groups randomly. Data were collected with Descriptive Questions Form, Menopause Symptom Evaluation Scale (MRS), FSFI, Marital adjustment Scale (MAS) and Sexual Quality of Life Questionnaire Scale - Female Version (SQOL-F) between September 07, 2020 and March 26, 2021. The intervention group was given sexual counselling, prepared in line with the PLISSIT model, for three weeks, once a week and lasting approximately one hour. The effect of the counseling was tested twelve weeks after counseling was completed. Women in the control group were also interviewed twice concurrent with the intervention group; once when the counseling began and once during the last assessment. Women in the control group filled some data forms. After the study was completed, the counseling was also given to women who wanted it, in the control group. Frequency and percentage values, descriptive statistics, Fisher's Exact Test, Pearson Chi Square, t tests, for non-normally distributed data Mann Whitney U test and the Wilcoxon test were used for data analysis. Keywords: Post-menopausal period, sexual counseling, PLISSIT model, nursing care

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 28, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 7, 2022

Completed
Last Updated

July 7, 2022

Status Verified

July 1, 2022

Enrollment Period

3 months

First QC Date

May 24, 2022

Last Update Submit

July 3, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Female Sexual Function Index

    Rosen et al \[2000\] developed this scale. It includes 19 items. Responses to some items range from 0 to 5 while others range from 1 to 5. The scores are summed up to create single Female Sexual Function Index score that ranges from 2 to 36. Higher scores mean better sexual functions.

    28.09.2020- 02.04.2021. The research period for a participant takes approximately four months.

  • Marital Adjustment Subscale

    It was developed by Locke and Wallace (1959) and consists of 15 items. The validity and reliability for Turkish translation was conducted by Kışlak-Tutarel (1999). The response range for the items are as the following: Item 1 = 0-6 points, Item 2 to 9 = 0-5 points, Items 10, 12, and 14 = 0-2 points, Items 11 and 13 = 0-3 points, and Item 15 = 0-2 points. The scale minimum value is 0 and maximum value is 58. Higher scores mean better marital adjustment.

    28.09.2020- 02.04.2021. The research period for a participant takes approximately four months.

  • The Sexual Quality Of Life-Female

    It was developed by Symonds et al (2005) and consists of 18 items. Items are scored from 0 to 5. The scale minimum value is 0 and maximum value is 90. Higher scores mean better sexual quality in a women's life.

    28.09.2020- 02.04.2021. The research period for a participant takes approximately four months.

  • Menopause Rating Scale

    It was developed by Schneider et al (1992) The Turkish validity and reliability study was carried by Gürkan (2005). The scale has a minimum value of 0 and a maximum value of 44. Higher scores mean more symptoms in menopause.

    28.09.2020- 02.04.2021. The research period for a participant takes approximately four months.

Study Arms (2)

Sexual counseling intervention group according to the PLISSIT model

EXPERIMENTAL

Sexual counseling according to the PLISSIT model, randomized pretest-posttest

Other: Sexual counseling according to the PLISSIT model, randomized pretest-posttest

control

EXPERIMENTAL

Non-counseling group

Other: Sexual counseling according to the PLISSIT model, randomized pretest-posttest

Interventions

experimental and control ,a randomized pretest-posttest study to examine

Sexual counseling intervention group according to the PLISSIT modelcontrol

Eligibility Criteria

Age42 Years - 55 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPostmenopause, female
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being in the first year of postmenopause,
  • Living with spouse/partner,
  • Having an active sex life,
  • Being able to speak, understand and read Turkish,
  • Entering menopause naturally,
  • Living within the borders of Ankara province,
  • Not having menopause at an early or late age (over 40 years and under 55 years old),
  • Not taking hormone replacement therapy,
  • Not using herbal treatment for menopause (containing estrogen),
  • Not having a type of cancer that may affect sexual function,
  • Not receiving chemotherapy / radiotherapy,
  • No health problems (Hypertension, Diabetes, Cardiovascular disease, Urinary incontinence),
  • Not having a mental illness and/or not using drugs (antipsychotic drugs, Spironolactone, etc.),
  • Not being diagnosed with COVID in the last month,
  • Not having a sexual dysfunction diagnosis / treatment history in himself or his partner,
  • +1 more criteria

You may not qualify if:

  • Receiving sexual health counseling from another consultant during the working period,
  • Desiring to leave the research at any stage of the research,
  • Failure to attend at least one of the sexual health counseling sessions,
  • Not participating in the post-test,
  • Getting a diagnosis of COVID.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suleyman Demirel University

Isparta, 32500, Turkey (Türkiye)

Location

Study Officials

  • Gülten HÜ Koç, asst. prof.

    Hacettepe University

    STUDY DIRECTOR
  • Berna EH Dilbaz, professor

    Etlik Hastanesi

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The sample was divided into intervention and control groups sexual counseling based on the PLISSIT model
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 24, 2022

First Posted

July 7, 2022

Study Start

September 28, 2020

Primary Completion

December 26, 2020

Study Completion

February 26, 2021

Last Updated

July 7, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations